-
1
-
-
77951065603
-
-
Joint United Nations Programme on HIV/AIDS (UNAIDS) December
-
Joint United Nations Programme on HIV/AIDS (UNAIDS): AIDS Epidemic Update, December 2009. http://data.unaids.org/pub/ Report/2009/JC1700-Epi- Update-2009-en.pdf.
-
(2009)
AIDS Epidemic Update
-
-
-
2
-
-
9644301110
-
Early versus deferred antiretroviral multidrug therapy in infants infected with HIV type 1
-
DOI 10.1086/425739
-
Faye A, Le Chenadec J, Dollfus C, Thuret I, Douard D, Firtion G, et al., French Perinatal Study Group. Early versus deferred antiretroviral multidrug therapy in infants infected with HIV type 1. Clin Infect Dis 2004; 39:1692-1698. (Pubitemid 39578547)
-
(2004)
Clinical Infectious Diseases
, vol.39
, Issue.11
, pp. 1692-1698
-
-
Faye, A.1
Le Chenadec, J.2
Dollfus, C.3
Thuret, I.4
Douard, D.5
Firtion, G.6
Lachassinne, E.7
Levine, M.8
Nicolas, J.9
Monpoux, F.10
Tricoire, J.11
Rouzioux, C.12
Tardieu, M.13
Mayaux, M.J.14
Blanche, S.15
-
3
-
-
56749097184
-
CHer Study Team. Early antiretroviral therapy and mortality among HIV-infected infants
-
Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, et al., CHer Study Team. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008; 359:2233-2244.
-
(2008)
N Engl J Med
, vol.359
, pp. 2233-2244
-
-
Violari, A.1
Cotton, M.F.2
Gibb, D.M.3
Babiker, A.G.4
Steyn, J.5
Madhi, S.A.6
-
4
-
-
63149144501
-
Effect of early antiretroviral therapy on the risk of AIDS/death in HIVinfected infants
-
European Infant Collaboration Group
-
Goetghebuer T, Haelterman E, Le Chenadec J, Dollfus C, Gibb D, Judd A, et al., European Infant Collaboration Group. Effect of early antiretroviral therapy on the risk of AIDS/death in HIVinfected infants. AIDS 2009; 23:597-604.
-
(2009)
AIDS
, vol.23
, pp. 597-604
-
-
Goetghebuer, T.1
Haelterman, E.2
Le Chenadec, J.3
Dollfus, C.4
Gibb, D.5
Judd, A.6
-
6
-
-
79953060644
-
-
Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children US Department of Health and Human Services. 23 February [Accessed 1 July 2010]
-
Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children: guidelines for the use of antiretroviral agents in pediatric HIV infection. US Department of Health and Human Services. 23 February 2009; pp. 1-139. http://aidsinfo.nih.gov/ContentFiles/PediatricGuidelines.pdf. [Accessed 1 July 2010].
-
(2009)
Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection
, pp. 1-139
-
-
-
7
-
-
73549109441
-
Update on antiretroviral therapy in paediatrics
-
Penazzato M, Donà D, Wool PS, Rampon O, Giaquinto C. Update on antiretroviral therapy in paediatrics. Antiviral Res 2010; 85:266-275.
-
(2010)
Antiviral Res
, vol.85
, pp. 266-275
-
-
Penazzato, M.1
Donà, D.2
Wool, P.S.3
Rampon, O.4
Giaquinto, C.5
-
8
-
-
63449084340
-
Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: Pharmacokinetics and 24-week safety and efficacy
-
International Maternal Pediatric Adolescent Clinical Trials Group (IMPAACT) P1030 Team
-
Chadwick EG, Pinto J, Yogev R, Alvero CG, Hughes MD, Palumbo P, et al., International Maternal Pediatric Adolescent Clinical Trials Group (IMPAACT) P1030 Team. Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: pharmacokinetics and 24-week safety and efficacy. Pediatr Infect Dis J 2009; 28:215-219.
-
(2009)
Pediatr Infect Dis J
, vol.28
, pp. 215-219
-
-
Chadwick, E.G.1
Pinto, J.2
Yogev, R.3
Alvero, C.G.4
Hughes, M.D.5
Palumbo, P.6
-
9
-
-
37549058774
-
Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results
-
P1030 Team
-
Chadwick EG, Capparelli EV, Yogev R, Pinto JA, Robbins B, Rodman JH, et al., P1030 Team. Pharmacokinetics, safety and efficacy of lopinavir/ritonavir in infants less than 6 months of age: 24 week results. AIDS 2008; 22:249-255.
-
(2008)
AIDS
, vol.22
, pp. 249-255
-
-
Chadwick, E.G.1
Capparelli, E.V.2
Yogev, R.3
Pinto, J.A.4
Robbins, B.5
Rodman, J.H.6
-
10
-
-
79952455300
-
-
Centers for Disease Control and Prevention Growth Charts
-
Centers for Disease Control and Prevention Growth Charts. www.cdc.gov/growthcharts.
-
-
-
-
11
-
-
34248165997
-
Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States
-
DOI 10.1086/513871
-
Persaud D, Palumbo P, Ziemniak C, Chen J, Ray SC, Hughes M, et al., Pediatric AIDS Clinical Trials Group P1030 Team. Early archiving andpredominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States. J Infect Dis 2007; 195:1402-1410. (Pubitemid 46717457)
-
(2007)
Journal of Infectious Diseases
, vol.195
, Issue.10
, pp. 1402-1410
-
-
Persaud, D.1
Palumbo, P.2
Ziemniak, C.3
Chen, J.4
Ray, S.C.5
Hughes, M.6
Havens, P.7
Purswani, M.8
Gaur, A.H.9
Chadwick, E.G.10
-
12
-
-
0037344230
-
Forty-eight-week evaluation of lopinavir/ ritonavir, a new protease inhibitor, in human immunode-ficiency virus-infected children
-
Sáez-Llorens X, Violari A, Deetz CO, Rode RA, Gomez P, Handelsman E, et al. Forty-eight-week evaluation of lopinavir/ ritonavir, a new protease inhibitor, in human immunode-ficiency virus-infected children. Pediatr Infect Dis J 2003; 22:216-224.
-
(2003)
Pediatr Infect Dis J
, vol.22
, pp. 216-224
-
-
Sáez-Llorens, X.1
Violari, A.2
Deetz, C.O.3
Rode, R.A.4
Gomez, P.5
Handelsman, E.6
-
13
-
-
0003683811
-
-
Abbott Laboratories, Abbott Park IL Kaletra (lopinavir/ritonavir)
-
Abbott Laboratories, Abbott Park, IL: Product information. Kaletra (lopinavir/ritonavir). Available at http://www.rxabbott. com/pdf/kaletratabpi. pdf.
-
Product Information
-
-
-
14
-
-
33646048331
-
Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection
-
Italian Register for HIV Infection in Children
-
Chiappini E, Galli L, Tovo PA, Gabiano C, Gattinara GC, Guarino A, et al., Italian Register for HIV Infection in Children. Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection. AIDS 2006; 20:207-215.
-
(2006)
AIDS
, vol.20
, pp. 207-215
-
-
Chiappini, E.1
Galli, L.2
Tovo, P.A.3
Gabiano, C.4
Gattinara, G.C.5
Guarino, A.6
-
15
-
-
49849094748
-
Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants
-
Prendergast A, Mphatswe W, Tudor-Williams G, Rakgotho M, Pillay V, Thobakgale C, et al. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants. AIDS 2008; 22:1333-1343.
-
(2008)
AIDS
, vol.22
, pp. 1333-1343
-
-
Prendergast, A.1
Mphatswe, W.2
Tudor-Williams, G.3
Rakgotho, M.4
Pillay, V.5
Thobakgale, C.6
-
16
-
-
73249132461
-
The changing pattern of adherence to antiretroviral therapy assessed at two time points, 12 months apart, in a cohort of HIV-infected children
-
Giannattasio A, Albano F, Giacomet V, Guarino A. The changing pattern of adherence to antiretroviral therapy assessed at two time points, 12 months apart, in a cohort of HIV-infected children. Expert Opin Pharmacother 2009; 10:2773-2778.
-
(2009)
Expert Opin Pharmacother
, vol.10
, pp. 2773-2778
-
-
Giannattasio, A.1
Albano, F.2
Giacomet, V.3
Guarino, A.4
-
17
-
-
70449393899
-
Five-year follow-up of children with perinatal HIV-1 infection receiving early highly active antiretroviral therapy
-
Chiappini E, Galli L, Tovo PA, Gabiano C, Lisi C, Bernardi S, et al. Five-year follow-up of children with perinatal HIV-1 infection receiving early highly active antiretroviral therapy. BMC Infect Dis 2009; 9:140.
-
(2009)
BMC Infect Dis
, vol.9
, pp. 140
-
-
Chiappini, E.1
Galli, L.2
Tovo, P.A.3
Gabiano, C.4
Lisi, C.5
Bernardi, S.6
-
18
-
-
67651083739
-
Immune reconstitution inflammatory syndrome among HIVinfected South African infants initiating antiretroviral therapy
-
Smith K, Kuhn L, Coovadia A, Meyers T, Hu CC, Reitz C, et al. Immune reconstitution inflammatory syndrome among HIVinfected South African infants initiating antiretroviral therapy. AIDS 2009; 23:1097-1107.
-
(2009)
AIDS
, vol.23
, pp. 1097-1107
-
-
Smith, K.1
Kuhn, L.2
Coovadia, A.3
Meyers, T.4
Hu, C.C.5
Reitz, C.6
-
19
-
-
0000406478
-
Rationale for attention to cholesterol levels in children and adolescents
-
National Cholesterol Education Program Expert Panel on Blood Cholesterol Levels in Children and Adolescents
-
National Cholesterol Education Program Expert Panel on Blood Cholesterol Levels in Children and Adolescents: Rationale for attention to cholesterol levels in children and adolescents. Pediatrics 1992; 89(Suppl):528-536.
-
(1992)
Pediatrics
, vol.89
, Issue.SUPPL.
, pp. 528-536
-
-
-
20
-
-
48249093075
-
Lipid screening and cardiovascular health in childhood
-
The AAP Committee on Nutrition
-
Daniels SR, Greer FR, The AAP Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics 2008; 122:198-208.
-
(2008)
Pediatrics
, vol.122
, pp. 198-208
-
-
Daniels, S.R.1
Greer, F.R.2
-
21
-
-
0344760902
-
-
Panel on Antiretroviral Guidelines for Adults and Adolescents U.S. Department of Health and Human Services; December [Accessed 1 July 2010] (p. 156, Appendix B, Table 3)
-
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. U.S. Department of Health and Human Services; December 2009. pp. 1-161. Available at http:// www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL. pdf. [Accessed 1 July 2010] (p. 156, Appendix B, Table 3).
-
(2009)
Guidelines for the Use of Antiretroviral Agents in HIV-1-infected Adults and Adolescents
, pp. 1-161
-
-
-
22
-
-
77957951312
-
Antiretroviral treatment for children with peripartum nevirapine exposure
-
Palumbo P, Lindsey J, Hughes M, Cotton MF, Bobat R, Meyers T, et al. Antiretroviral treatment for children with peripartum nevirapine exposure. N Engl J Med 2010; 363:1510-1520.
-
(2010)
N Engl J Med
, vol.363
, pp. 1510-1520
-
-
Palumbo, P.1
Lindsey, J.2
Hughes, M.3
Cotton, M.F.4
Bobat, R.5
Meyers, T.6
-
23
-
-
77953724252
-
-
National Department of Health, South Africa 2nd ed
-
National Department of Health, South Africa. Guidelines for the management of HIV in Children. 2nd ed. 2010. http://www. who.int/hiv/pub/ paediatric/WHO-Paediatric-ART-guideline- rev-mreport-2008.pdf.
-
(2010)
Guidelines for the Management of HIV in Children
-
-
|